Suppr超能文献

西酞普兰在难治性猝倒症中的应用。

The use of citalopram in resistant cataplexy.

作者信息

Thirumalai SS, Shubin RA

机构信息

Huntington Hospital Sleep Disorders Center, 100 West California Boulevard, CA 91107, Pasadena, USA

出版信息

Sleep Med. 2000 Oct 1;1(4):313-316. doi: 10.1016/s1389-9457(00)00026-5.

Abstract

Background: Cataplexy is a disabling component of the narcolepsy tetrad that is sometimes resistant to standard treatment.Case reports: Three of our patients with narcolepsy, including one who had post-traumatic narcolepsy, suffered from intractable cataplexy with failure of treatment with established drugs due to unacceptable side-effects.Results: We explored the use of citalopram (Celexa), the newest and most specific of the serotonin reuptake inhibitors, and were successful in treating cataplexy without significant side-effects. Stimulant drugs remained necessary for controlling symptoms of excessive drowsiness.Conclusions: Citalopram was effective in relieving the symptoms of resistant cataplexy in out patients.

摘要

背景

猝倒是发作性睡病四联症的致残性组成部分,有时对标准治疗有抵抗性。

病例报告

我们的三名发作性睡病患者,包括一名创伤后发作性睡病患者,患有难治性猝倒,因无法接受的副作用,使用既定药物治疗失败。

结果

我们探索使用西酞普兰(喜普妙),这是最新且最具特异性的5-羟色胺再摄取抑制剂,成功治疗了猝倒且无明显副作用。仍需要使用兴奋剂药物来控制过度嗜睡症状。

结论

西酞普兰有效缓解了我们患者中难治性猝倒的症状。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验